Advertisement

Associated Diseases in IgA Nephropathy

  • Jukka Mustonen
  • Amos Pasternack
Chapter
Part of the Topics in Renal Medicine book series (TIRM, volume 2)

Abstract

In the original study by Berger [1], IgA nephropathy was described as a primary glomerulonephritis and also in patients with Henoch-Schönlein purpura. Soon thereafter, Manigand et al. [2] found that glomerular IgA deposits were often present in association with alcoholic liver cirrhosis. During the 1970s and 1980s, IgA nephropathy has been found to coexist with several types of diseases as presented in table 5–1 [1–38].

Keywords

Ankylose Spondylitis Celiac Disease Alcoholic Liver Disease Dermatitis Herpetiformis Alcoholic Liver Cirrhosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Berger J: IgA glomerular deposits in renal disease. Transplant Proc: 1:939–944, 1969.PubMedGoogle Scholar
  2. 2.
    Manigand G, Morel-Maroger L, Simon J, Deparis M: Lésions rénales glomérulaires et cirrhose du foie: note préliminaire sur les lésions histologiques de rein au cours des cirrhoses hépatiques, d’après 20 prélèvements biopsiques. Rev Ëur Etud Clin Biol 15:989–996, 1970.PubMedGoogle Scholar
  3. 3.
    Nakamoto Y, Hattori N, Yakeuchi J: Primary IgA glomerulonephritis and Schönlein-Henoch purpura nephritis: clinicopathological and immunohistological characteristics. Q J Med 48:495–516, 1978.Google Scholar
  4. 4.
    Weiss JH, Bhathena DB, Curtis JJ, Lucas BA, Luke RG: A possible relationship between Henoch-Schönlein syndrome and I nephropathy (Berger’s disease). Nephron 22:582–591, 1978.PubMedCrossRefGoogle Scholar
  5. 5.
    Sissons JGP, Woodrow DF, Curtis JR, Evans DJ, Gower PE, Sloper JC, Peters DK: Isolated glomerulonephritis with mesangial I deposits. Br Med J 3:611–614, 1975.PubMedCrossRefGoogle Scholar
  6. 6.
    Bailey RR, Burry AF, McGiven AR, Kirk JA, Laing JK, Moller P: A renal lesion in ankylosing spondylitis. Nephron 26:171–173, 1980.PubMedCrossRefGoogle Scholar
  7. 7.
    Jennette JC, Ferguson AL, Moore MA, Freeman DG. IgA nephropathy associated with seronegative spondylarthopathies. Arthritis Rheum 25:144–149, 1982.PubMedCrossRefGoogle Scholar
  8. 8.
    Dard S, Kenouch S, Mery JPh, Baumelou A, Beaufils H: Une nouvelle association: spondylarthrite ankylosante et maladie de Berger. Néphrologie 3:183, 1982.Google Scholar
  9. 9.
    Krothapalli R, Neeland B, Small S, Duffy WB, Gyorkey F, Senekjian HO. IgA nephropathy in a patient with ankylosing spondylitis and a solitary kidney. Clin Nephrol 21:134–137, 1984.PubMedGoogle Scholar
  10. 10.
    Lagrue G, Bruneau C, Intrator L, Laurent J: IgA nephropathy associated with seronegative spondylarthropathies: efficacy of non steroidal anti-inflammatory drugs (NSAIDs). Clin Nephrol 23:107–108, 1985.PubMedGoogle Scholar
  11. 11.
    Burkholder PM, Zimmermann SW, Moorthy AV: A clinicopathologic study of the natural history of mesangial IgA nephropathy. In: Yoshitoshiy, Ueda (eds) Glomerulonephritis. Baltimore: University Park Press, 1979.Google Scholar
  12. 12.
    Brun C, Olsen S: Atlas of renal biopsy. Copenhagen: Munksgaard, 1981, p 110.Google Scholar
  13. 13.
    Forsström J, Viander M, Lehtonen A, Ekfors T: Yersinia enterocolitica infection complicated by glomerulonephritis. Scand J Infect Dis 9:253–256, 1977.PubMedGoogle Scholar
  14. 14.
    Cusack D, Martin P, Schinittger T, McCafferky M, Keane C, Keogh B: IgA nephropathy in association with Yersinia enterocolitica. Irish J Med Sci 152:311–312, 1983.PubMedCrossRefGoogle Scholar
  15. 15.
    Spargo BH, Seymour AE, Ordonez NG: Mesangial proliferative glomerulonephritis. In: Renal biopsy pathology with diagnostic and therapeutic implications, New York: John Wiley and Sons, 1980, pp 71–82.Google Scholar
  16. 16.
    Helin H, Mustonen J, Reunala T, Pasternack A: IgA nephropathy associated with celiac disease and dermatitis herpetiformis. Arch Pathol Lab Med 107:324–327, 1983.PubMedGoogle Scholar
  17. 17.
    Makdassy R, Beaufils M, Meyrier A, Mignon F, Molonguet-Doleris L, Richet G: Pathologic conditions associated with IgA mesangial nephropathy: preliminary results. Contrib Nephrol 40:292–295, 1984.PubMedGoogle Scholar
  18. 18.
    Clarkson AR, Woodroffe AJ, Bannister KM, Lomax-Smith JD, Aarons IgA: The syndrome of I nephropathy. Clin Nephrol 21:7–14, 1984.PubMedGoogle Scholar
  19. 19.
    Callard P, Feldmann G, Prandi D, Beiair MF, Mandet C, Weiss Y, Druet P, Benhamou JP, Bariety J: Immune complex type glomerulonephritis in cirrhosis of the liver. Am J Pathol 80:329–340, 1975.PubMedGoogle Scholar
  20. 20.
    Berger J, Yaneva H, Nabarra B: Glomerular changes in patients with cirrhosis of the liver. Adv Nephrol 7:3–14, 1978.Google Scholar
  21. 21.
    Nakamoto Y, Iida H, Kobayashi K, Dohi K, Kida H, Hattori N, Takeuchi J: Hepatic glomerulonephritis: characteristics of hepatic IgA glomerulonephritis as the major part. Virchows Archiv [Pathol Anat] 392:45–54, 1981.CrossRefGoogle Scholar
  22. 22.
    Nochy D, Callard P, Bellon B, Bariety J, Druet P: Association of overt glomerulonephritis and liver disease: a study of 34 patients. Clin Nephrol 6:422–427, 1976.PubMedGoogle Scholar
  23. 23.
    Pape JF, Mellbye OJ, Oystese B, Browall EK: Glomerulonephritis in dermatitis herpetiformis. Acta Med Scand 203:445–448, 1978.PubMedCrossRefGoogle Scholar
  24. 24.
    Nomoto Y, Sakai H, Endoh M, Tomino Y: Scleritis and IgA nephropathy. Arch Intern Med 140:783–785, 1980.PubMedCrossRefGoogle Scholar
  25. 25.
    Endoh M, Kaneshige H, Tomino Y, Nomoto Y, Sakai H, Arimori S, Shinbo T, Ishihara T: IgA nephropathy associated with myasthenia gravis and scleritis. Tokai J Exp Clin Med 6:421–425, 1981.PubMedGoogle Scholar
  26. 26.
    De Ligny BH, Sirbat D, Bene MC, Faure G, Kessler M: Scleritis associated with glomerulonephritis. Nephron 35:207, 1983.CrossRefGoogle Scholar
  27. 27.
    Nash H, Binns GF, Clarkson AR, Beare TH: Concomitant IgA nephropathy and cyclical neutropaenia. Aust NZ J Med 8:184–188, 1978.CrossRefGoogle Scholar
  28. 28.
    Hookerjee BK, Maddison PJ, Reichlin M: Mesangial IgA-IgG deposition in mixed cryoglobulinemia. Am J Med Sci 276:221–225, 1978.CrossRefGoogle Scholar
  29. 29.
    Spichtin HP, Truniger B, Mihatsch MJ, Bucher U, Gudat F, Zollinger HU: Immunothrombocytopenia and IgA nephritis. Clin Nephrol 14:304–308, 1980.PubMedGoogle Scholar
  30. 30.
    Cairns SA, Mallick NP, Lawler W, Williams G: Squamous cell carcinoma of bronchus presenting with Henoch-Schönlein purpura. Br Med J 2:474–475, 1978.PubMedCrossRefGoogle Scholar
  31. 31.
    Mustonen J, Helin H, Pasternack A: IgA nephropathy associated with bronchial small-cell carcinoma. Am J Clin Pathal 76:652–656, 1981.Google Scholar
  32. 32.
    Dosa S, Cairns SA, Mallick NP, Lawler W, Willians G: Relapsing Henoch-Schönlein syndrome with renal involvement in a patient with IgA monoclonal gammopathy. Nephron 26:145–148, 1980.PubMedCrossRefGoogle Scholar
  33. 33.
    Ramirez G, Stinson JB, Zawada ET, Moatamed F: IgA nephritis associated with mycosis fungoides. Arch Intern Med 141:1287–1291, 1981.PubMedCrossRefGoogle Scholar
  34. 34.
    Sinniah R: Mucin-secreting cancer with mesangial IgA deposits. Pathology 14:303–308, 1982.PubMedCrossRefGoogle Scholar
  35. 35.
    Yum MN, Lampton LM, Bloom PM, Edwards JL: Asymptomatic IgA nephropathy associated with pulmonary hemosiderosis. Am J Med 64:1056–1060, 1978.PubMedCrossRefGoogle Scholar
  36. 36.
    Valles M, Cantarell C, Fort J, Carrera M: IgA nephropathy in leprosy. Arch Intern Med 142:1238, 1982.PubMedCrossRefGoogle Scholar
  37. 37.
    Wyatt RJ, Julian BA, Galla JH: Properdin deficiency with I nephropathy. N Engl J Med 305:1097, 1981.PubMedGoogle Scholar
  38. 38.
    Woodroffe AJ: IgA, glomerulonephritis and liver disease. Aust NZ J Med [Suppl 1] 11:109–111, 1981.CrossRefGoogle Scholar
  39. 39.
    Battle DC: IgA glomerulonephritis, asymptomatic hematuria, and systemic disease. Arch Intern Med 141:1264–1265, 1981.CrossRefGoogle Scholar
  40. 40.
    Cameron JS: Glomerulonephritis in renal transplants. Transplantation 34:237–245, 1982.PubMedCrossRefGoogle Scholar
  41. 41.
    Churg J, Sobin LH: Classification and atlas of glomerular diseases Tokyo: Igaku-Shoin, 1982.Google Scholar
  42. 42.
    Bloodworth JBM, Sommers SC: Cirrhotic glomerulosclerosis: a renal lesion associated with hepatic cirrhosis. Lab Invest 8:962–978, 1959.PubMedGoogle Scholar
  43. 43.
    Sinniah R: Heterogenous IgA glomerulonephropathy in liver cirrhosis. Histopathology 8:947–962, 1984.PubMedCrossRefGoogle Scholar
  44. 44.
    Woodroffe AJ, Gormly AA, McKenzie PE, Wootton AM, Thompson AJ, Seymour AE, Clarkson AR: Immunologic studies in IgA nephropathy. Kidney Int 18:366–374, 1980.PubMedCrossRefGoogle Scholar
  45. 45.
    Bene MC, Faure G, De Korvin J, De Ligny B, Kessler M, Gaucher P, Duheille J: Renal and hepatic immunohistopathology of cirrhosis [abstr] Kidney Int 26:227, 1984.Google Scholar
  46. 46.
    Lee FJ: Immunoglobulins in viral hepatitis and active alcoholic liver disease. Lancet 2:1043–1046, 1965.PubMedCrossRefGoogle Scholar
  47. 47.
    Van de Wiel A, Schurrman HJ, Kater L: Immunoglobulin A in alcoholic liver disease. Contrib Nephrol 40:276–282, 1984.PubMedGoogle Scholar
  48. 48.
    Kater L, Jöbsis AC, Baart de la Faille-Kuyper EH, Vögten AJM, Grijm R: Alcoholic hepatic disease: specificity of I deposits in liver. Am J Clin Pathol 71:51–57, 1979.PubMedGoogle Scholar
  49. 49.
    Swerdlow MA, Chowdhury LN, Mishra V, Kavin H: IgA deposits in skin in alocholic liver disease. J Am Acad Dermatol 9:232–236, 1983.PubMedCrossRefGoogle Scholar
  50. 50.
    Kutteh WH, Prince SJ, Phillips JO, Spenney JG, Mestecky J: Properties of immunoglobulin A in serum of individuals with liver diseases and in hepatic bile. Gastroenterology 82:184–193, 1982.PubMedGoogle Scholar
  51. 51.
    Kalsi J, Delacroix DL, Hodgson HJF: IgA in alcoholic cirrhoisis. Clin Exp Immunol 52:499–504, 1983.PubMedGoogle Scholar
  52. 52.
    Sancho J, Egido J, Sánchez-Crespo M, Blasco R: Detection of monomeric and polymeric IgA containing immune complexes in serum and kidney from patients with alcoholic liver disease. Clin Exp Immunol 47:327–335, 1981.Google Scholar
  53. 53.
    Delacroix DL, Elkon KB, Geubel AP, Hodgson HF, Dive C, Vaerman JP: Changes in size, subclass, and metabolic properties of serum immunoglobulin A in liver diseases and in other diseases with high serum immunoglobulin A. J Clin Invest 71:358–367, 1983.PubMedCrossRefGoogle Scholar
  54. 54.
    Bjørneboe M, Prytz H, Ørskov F: Antibodies to intestinal microbes in serum of patients with cirrhosis of the liver. Lancet 1:58–63, 1972.PubMedCrossRefGoogle Scholar
  55. 55.
    Triger DR, Alp MH, Wright R: Bacterial and dietary antibodies in liver diseases. Lancet 1:60–63, 1972.PubMedCrossRefGoogle Scholar
  56. 56.
    Chandy KG, Hubscher SG, Elias E, Berg J, Khan M: Dual role of the liver in regulating circulating polymeric IgA in man: studies on patients with liver disease. Clin Exp Immunol 52:207–218, 1983.PubMedGoogle Scholar
  57. 57.
    Orlans E, Peppard J, Reynolds J, Hall JG: Rapid active transport of IgA from blood to bile in rats. J Exp Med 147:588–602, 1978.PubMedCrossRefGoogle Scholar
  58. 58.
    Kaartinen M: Liver damage in mice and rats causes ten-fold increase of blood immunoglobulin A. Scand J Immunol 7:519–522, 1978.PubMedCrossRefGoogle Scholar
  59. 59.
    Gormly AA, Smith PS, Seymour AE, Clarkson AR, Woodroffe AJ: IgA glomerular deposits in experimental cirrhosis. Am J Pathol 104:50–54, 1981.PubMedGoogle Scholar
  60. 60.
    Melvin T, Burke B, Michael AF, Kim Y: Experimental IgA nephropathy in bile duct ligated rats. Clin Immunol Immunopathol 27:369–377, 1983.PubMedCrossRefGoogle Scholar
  61. 61.
    McKeever U, O’Mahony C, Whelan CA, Weir DG: Helper and suppressor T-lymphocyte function in severe alcoholic liver disease. Clin Exp Immunol 60:39–48, 1985.PubMedGoogle Scholar
  62. 62.
    Woodroffe AJ: Discussion. Contrib Nephrol 40:296–301, 1984.Google Scholar
  63. 63.
    Nochy D, Druet P, Bariety J: IgA nephropathy in chronic liver disease. Contrib Nephrol 40:268–275, 1984.PubMedGoogle Scholar
  64. 64.
    Cooper BT, Holmes GKT, Cooke WT: Coeliac disease and immunologic disorders. Br Med J 1:537–539, 1978.PubMedCrossRefGoogle Scholar
  65. 65.
    Scott BR, Losowsky MS: Celiac disease: a cause of various associated diseases? Lancet 2:596–957, 1975.Google Scholar
  66. 66.
    Asquith P, Thompson RA, Cooke WT: Serum-immunoglobulins in adult coeliac disease. Lancet 2:129–131, 1969.PubMedCrossRefGoogle Scholar
  67. 67.
    Hall RP, Strober W, Katz SI, Lawley TJ: IgA-containing circulating immune complexes in gluten-sensitive enteropathy. Clin Exp Immunol 45:234–239, 1981.PubMedGoogle Scholar
  68. 68.
    Unsworth DJ, Payne AW, Leonard JN, Fry L, Holborow EJ: IgA in dermatitis-herpetiformis skin is dimeric. Lancet 1:478–480, 1982.PubMedCrossRefGoogle Scholar
  69. 69.
    Leonard J, Halffenden G, Tucker W, Unsworth J, Swain F, McMinn R, Holborow J, Fry L: Gluten challenge in dermatitis herpetiformis. N Engl J Med 308:816–819, 1983.PubMedCrossRefGoogle Scholar
  70. 70.
    Westberg NG, Baklien K, Schmekel B, Gillberg R, Brandtzaeg P: Quantitation of immunoglobulin-producing cells in small intestinal mucosa of patients with IgA nephropathy. Clin Immunol Immunopathol 26:442–445, 1983.PubMedCrossRefGoogle Scholar
  71. 71.
    Pasternack A, Heiin H, Törnroth T, Rantala I, Väisänen J, Rahka R: Aspiration biopsy of the kidney with a new fine needle: a way to obtain glomeruli for morphological study. Clin Nephrol 10:79–84, 1978.PubMedGoogle Scholar
  72. 72.
    Rantala I, Laasonen A, Pasternack A, Mustonen J: Immunofluorescence microscopy of paraffin-embedded human kidney specimens obtained by fine-needle aspiration biopsy. Am J Clin Pathol 79:489–492, 1983.PubMedGoogle Scholar
  73. 73.
    Mustonen J: IgA glomerulonephritis and associated diseases. Ann Clin Res 16:161–166, 1984.PubMedGoogle Scholar
  74. 74.
    Glassock RJ, Cohen AH, Bennett CM, Martinez-Maldonado M: In: Brenner BM, Rector FC (eds) The kidney. Philadelphia: WB Saunders, 1981, pp 1400–1401.Google Scholar
  75. 75.
    Meadow SR, Scott DG: Berger disease: Henoch-Schönlein syndrome without the rash. J Pediatr 106:27–32, 1985.PubMedCrossRefGoogle Scholar
  76. 76.
    Linder E, Pasternack A: Immunofluorescence studies on kidney biopsies in ankylosing spondylitis. Acta Pathol Microbiol Scand [B] 78:517–525, 1970.Google Scholar
  77. 77.
    Kinsella TD, Espinoza L, Vasey FB: Serum complement and immunoglobulin levels in sporadic and familial ankylosing spondylitis. J Rheumatol 2:308–313, 1975.PubMedGoogle Scholar
  78. 78.
    Cowling P, Ebringer R, Ebringer A: Association of inflammation with raised serum IgA in ankylosing spondylitis. Ann Rheum Dis 39:545–549, 1980.PubMedCrossRefGoogle Scholar
  79. 79.
    Calguneri M, Swinburne L, Shinebaum R, Cooke EM, Wright V: Secretory IgA: immune defence pattern in ankylosing spondylitis and klebsiella. Ann Rheum Dis 40:600–604, 1981.PubMedCrossRefGoogle Scholar
  80. 80.
    Granfors K: Measurement of immunoglobulin M (IgA), IgA, and IgA antibodies against Yersinia enterocolitica by enzyme-linked immunosorbent assay: persistence of serum antibodies during disease. J Clin Microbiol 9:336–341, 1979.PubMedGoogle Scholar
  81. 81.
    Wright V: A unifying concept for the spondylarthropathies. Clin Orthop 143:8–14, 1979.PubMedGoogle Scholar
  82. 82.
    Steinsson K, Hirszel P, Weinstein A: Mesangial IgM nephropathy in a patient with HLA-B27 spondylarthropathy. Arthritis Rheum 26:1056, 1983.PubMedCrossRefGoogle Scholar
  83. 83.
    Baldwin DS, Gluck MC, Lowenstein J, Gallo GR: Lupus nephritis: clinical course as related to morphologic forms and their transitions. Am J Med 62:12–30, 1977.PubMedCrossRefGoogle Scholar
  84. 84.
    Burkholder PM: Nephritis associated with systemic lupus erythematosus. In: Atlas of human glomerular pathology. New York: Harper and Row, 1974.Google Scholar
  85. 85.
    Nomoto Y, Sakai H: Cold-reacting antinuclear factor in sera from patients with IgA nephropathy. J Lab Clin Med 94:76–87, 1979.PubMedGoogle Scholar
  86. 86.
    Whitworth JA, Leibowitz S, Kennedy MC, Cameron JS, Chantier C: IgA and glomerular disease. Clin Nephrol 5:33–36, 1976.PubMedGoogle Scholar
  87. 87.
    Cameron JS: Discussion. Contrib Nephrol 40:296–301, 1984.Google Scholar
  88. 88.
    Bene MC, De Ligny BH, Sirbat D, Faure G, Kessler M, Duheille’J: IgA nephropathy: dimeric IgA-secreting cells are present in episcleral infiltrate. Am J Clin Pathol 82:608–611, 1984.PubMedGoogle Scholar
  89. 89.
    McGavin DDM, Williamson J, Forrester FV: Episcleritis and scleritis. Br J Ophthalmol 60:192–226, 1976.PubMedCrossRefGoogle Scholar
  90. 90.
    Lee JC, Yamauchi H, Hopper J: The association of cancer and the nephrotic syndrome. Ann Intern Med 64:41–51, 1966.PubMedGoogle Scholar
  91. 91.
    Eage W, Lewis EJ: Glomerulopathies of neoplasia. Kidney Int 11:297–306, 1977.CrossRefGoogle Scholar
  92. 92.
    Gagliano RG, Costanzi JJ, Beathard GA, Sarles HE, Bell JD: The nephrotic syndrome associated with neoplasia: an unusual paraneoplastic syndrome. Am J Med 60:1026–1031, 1976.PubMedCrossRefGoogle Scholar
  93. 93.
    Glassock RJ, Friedler RM, Massry SG: Kidney and electrolytic disturbances in neoplastic diseases. Contrib Nephrol 7:2–41, 1977.PubMedGoogle Scholar
  94. 94.
    Mustonen J, Pasternack A, Helin H: IgA mesangial nephropathy in neoplastic diseases. Contrib Nephrol 40:283–291, 1984.PubMedGoogle Scholar
  95. 95.
    Brown AM, Lally ET, Frankel A, Harwick R, Davis LW, Rominger CJ: The association of the IgA levels of serum and whole saliva with the progression of oral cancer. Cancer 35:1154–1162, 1975.PubMedCrossRefGoogle Scholar
  96. 96.
    Krant MJ, Manskopf GM, Brandrup CS, Madoff MA: Immunologic alterations in bronchogenic cancer. Cancer 21:623–631, 1968.PubMedCrossRefGoogle Scholar
  97. 97.
    Wara WM, Ammann AJ, Wara DW, Phillips TL: Serum IgA in the diagnosis of nasopharyngeal and paranasal sinus carcinoma. Radiology 116:409–411, 1975.PubMedGoogle Scholar
  98. 98.
    Zech P, Colon S, Pointet P, Deteix P, Labeeuw M, Leitienne P: The nephrotic syndrome in adults aged over 60: etiology, evolution and treatment of 76 cases. Clin Nephrol 18:232–236, 1982.Google Scholar
  99. 99.
    Mustonen J, Pasternack A, Rantala I: The nephrotic syndrome in IgA glomerulonephritis: response to corticosteroid therapy. Clin Nephrol 20:172–176, 1983.PubMedGoogle Scholar
  100. 100.
    Pascal RR, Innaccone PM, Rollwagen FM, Harding TA, Bennet SJ: Electron microscopy and immunofluorescence of glomerular immune deposits in cancer patients. Cancer Res 36:43–47, 1976.PubMedGoogle Scholar
  101. 101.
    Helin H, Pasternack A, Hakala T, Penttinen K, Wager O: Glomerular electron-dense deposits and circulating immune complexes in patients with malignant tumours. Clin Nephrol 14:23–30, 1980.PubMedGoogle Scholar
  102. 102.
    Falk GA, Siskind GW, Smith JP: Immunoglobulin elevations in the serum of patients with chronic bronchitis and emphysema. J Immunol 105:1559–1562, 1970.PubMedGoogle Scholar
  103. 103.
    Schwartz RH: Serum immunoglobulin levels in cystic fibrosis. Am J Dis Child 111:408–411, 1966.PubMedGoogle Scholar
  104. 104.
    Daniele RP, Daubert JH, Rossman MD: Immunologic abnormalities in sarcoidosis. Ann Intern Med 92:406–416, 1980.PubMedGoogle Scholar
  105. 105.
    Valassi-Adam H, Rouska A, Karpouzas J, Matsaniotis N: Raised IgA in idiopathic pulmonary haemosiderosis. Arch Dis Child 50:320–323, 1975.PubMedCrossRefGoogle Scholar
  106. 106.
    Habib R: Discussion. Contrib Nephrol 40:264–267, 1984.Google Scholar
  107. 107.
    Kincaid-Smith P, Nicholls K: Mesangial IgA nephropathy. Am J Kidney Dis 3:90–102, 1983.PubMedGoogle Scholar
  108. 108.
    Mustonen J, Pasternack A, Heiin H, Nikkilä M: Clinicopathologic correlations in a series of 143 patients with IgA glomerulonephritis. Am J Nephrol 5:150–157, 1985.PubMedCrossRefGoogle Scholar
  109. 109.
    Tsai CC, Giangiacomo J, Zuckner J: Dermal IgA deposits in Henoch-Schönlein purpura and Berger’s nephritis. Lancet 1:342–343, 1975.PubMedCrossRefGoogle Scholar
  110. 110.
    Baart de la Faille-Kuyper EH, Kater L, Kuijten RH, Kooiker CJ, Wagenaar SS, Van der Zouwen P, Mees EJD: Occurrence of vascular IgA deposits in clinically normal skin of patients with renal disease. Kidney Int 9:424–429, 1976.CrossRefGoogle Scholar
  111. 111.
    Clarkson AR, Seymour AE, Chan Y-L, Thompson AJ, Woodroffe AJ: Clinical, pathological, and therapeutic aspects of IgA nephropathy. In: Kincaid-Smith P, Apice AJF, Atkins RC (eds) Progress of glomerulonephritis. New York: John Wiley and Sons, 1979, pp 247–259.Google Scholar
  112. 112.
    Lamperi S, Carozzi S: Skin-muscle biopsy in patients with various nephropathies. Nephron 24:46–50, 1979.PubMedCrossRefGoogle Scholar
  113. 113.
    Tomino Y, Nomoto Y, Endoh M, Sakai H: Deposition of IgA-dominant immune complexes in muscular vessels from patients with IgA nephropathy. Acta Pathol Jpn 31:361–365, 1981.PubMedGoogle Scholar
  114. 114.
    Mustonen J, Pasternack A, Helin H, Rilva A, Penttinen K, Wager O, Harmoinen A: Circulating immune complexes, the concentration of serum IgA and the distribution of HLA antigens in IgA nephropathy. Nephron 29:170–175, 1981.PubMedCrossRefGoogle Scholar
  115. 115.
    Kammer GM, Soter NA, Gibson DF, Schur PH: Psoriatic arthritis: a clinical, immunologic and HLA study of 100 patients. Semin Arthritis Rheum 9:75–97, 1979.PubMedCrossRefGoogle Scholar
  116. 116.
    Rodnan GP: Progressive systemic sclerosis (scleroderma). In: Marty DJ (ed) Arthritis and allied conditions. Philadelphia: Lea and Febiger, 1979, p 762.Google Scholar
  117. 117.
    Egido J, Blasco R, Sancho J, Lozano L, Sánchez-Crespo M: Increased rates of polymeric IgA synthesis by circulating lymphoid cells in IgA mesangial glomerulonephritis. Clin Exp Immunol 47:309–316, 1982.PubMedGoogle Scholar
  118. 118.
    Endoh M, Suga T, Miura M, Tomino Y, Nomoto Y, Sakai H: In vivo alteration of antibody production in patients with IgA nephropathy. Clin Exp Immunol 57:564–570, 1984.PubMedGoogle Scholar
  119. 119.
    Pasternack A, Mustonen J, Leinikki P: Humoral immune response in patients with IgA and IgA glomerulonephritis. Clin Exp Immunol 63:228–223, 1986.PubMedGoogle Scholar
  120. 120.
    Andre C, Berthoux FC, Andre F, Gillon J, Genin C, Sabatier J-C: Prevalence of IgA2 deposits in IgA nephropathies. N Engl J Med 303:1343–1346, 1980.PubMedCrossRefGoogle Scholar
  121. 121.
    Conley ME, Cooper MD, Michael AF: Selective deposition of immunoglobulin Al in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. J Clin Invest 66:1432–1436, 1980.PubMedCrossRefGoogle Scholar
  122. 122.
    Conley ME, Koopman WJ: Serum IgAl and IgA2 in normal adults and patients with systemic lupus erythematosus and hepatic disease. Clin Immunol Immunopathol 26:390–397, 1983.PubMedCrossRefGoogle Scholar
  123. 123.
    Woodroffe AJ, Clarkson AR, Seymour AE, Lomax-Smith JD: Mesangial IgA nephritis. Springer Semin Immunopathol 5:321–332, 1982.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1987

Authors and Affiliations

  • Jukka Mustonen
  • Amos Pasternack

There are no affiliations available

Personalised recommendations